ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GDR Genedrive Plc

1.65
0.12 (7.84%)
07 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.12 7.84% 1.65 1.60 1.70 1.725 1.50 1.50 48,827,665 16:01:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0447 -0.37 1.9M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 1.53p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 20.75p.

Genedrive currently has 115,139,946 shares in issue. The market capitalisation of Genedrive is £1.90 million. Genedrive has a price to earnings ratio (PE ratio) of -0.37.

Genedrive Share Discussion Threads

Showing 6626 to 6648 of 26175 messages
Chat Pages: Latest  267  266  265  264  263  262  261  260  259  258  257  256  Older
DateSubjectAuthorDiscuss
11/2/2021
06:40
Bunz Aka Sharehunter , everyone knows is a paid RAMPER
oilisgold
11/2/2021
06:40
blah blah blah no, you are the going concern you twit...you sound so desperate. Don't tell me you have got a short on here?
jambam
11/2/2021
06:39
Same as last time. Will be pumped to 300p then the dump again
oilisgold
11/2/2021
06:38
That was from Nov RNS, the Rampers have got rose tinted specs on
oilisgold
11/2/2021
06:38
Looks like placing on the way to me.
oilisgold
11/2/2021
06:37
Going concern

We have experienced delays commercialising the Genedrive® 96 SARS CoV-2 test and the lack of revenue has impacted our cash position. However we continue to focus on obtaining product approvals and securing sales and we are managing the cost base until revenues are assured. We are confident in our sales forecasts but securing cash generative revenue in the forthcoming months is necessary otherwise the Group will haveto reduce costs and raise additional funds. We continue to adopt a going concern basis for the preparation of the accounts, but the combination of the above factors represents a material uncertainty that may cast significant doubt on the Group and Company's ability to continue as a going concern.

oilisgold
10/2/2021
23:50
In case anyone needs reminding:

"genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it has entered into a distribution agreement with Beckman Coulter Life Sciences ("Beckman Coulter") for its Genedrive(R) 96 SARS-CoV-2 Kit. The agreement enables Beckman Coulter to sell and distribute genedrive's high-throughput COVID-19 PCR Kit in the United States and Europe for use on upper respiratory viral samples. The agreement is the result of the collaboration agreement announced in August 2020, under which the companies worked to develop and validate a fully automated PCR process for Beckman Coulter's Biomek automated workstation in conjunction with its RNAdvance Viral XP extraction kit.

The Genedrive(R) 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument."

aquilla
10/2/2021
23:40
From the LSE site:

"Good news.
Looks like the new fully automated Bio meks are already getting rolled out to help the lab technicians across the USA.
ALSO looks like demand is through the roof!!!
"We put the order in two months before we got it,” she said. “The day after we placed the order, the company told us if we hadn’t ordered it then, we would have had another several months of wait time.
"The whole country is looking for automation"
THE WHOLE COUNTRY
THE WHOLE OF THE USA"

aquilla
10/2/2021
22:47
oilisgold, sad to see any one posting the posts you posting about this share


peoplehave posted the money gdr have


and peoplwe have also posted gdr

have no debt


so you not fool any one who has done


their research


you might try and get less experienced investors to sell



hope other investors as well as myself will post and try and help other people not


to be mislead ,all investors


do your own research ,d y o r

bunz3
10/2/2021
22:35
Placing on its way.
oilisgold
10/2/2021
22:34
Basically company has run out of cash.
oilisgold
10/2/2021
22:34
are confident in our sales forecasts but securing cash generative revenue in the forthcoming months is necessary otherwise the Group will haveto reduce costs and raise additional funds. We continue to adopt a going concern basis for the preparation of the accounts, but the combination of the above factors represents a material uncertainty that may cast significant doubt on the Group and Company's ability to continue as a going
oilisgold
10/2/2021
22:23
oilisgold+. you trying so hard to damage this share price


people can see through your posting
no matter how many posts you post night and day deramping gdr


the buyers still loading up as many of them have done their research


and read the rns

bunz3
10/2/2021
22:05
Put Oily on filter. A waste of space. You will be better for it. Ignore it.
sellsell
10/2/2021
21:28
Like it was pumped to 300p. Rinse and repeat
oilisgold
10/2/2021
21:28
I warned you all, this was being pumped for a placing.
oilisgold
10/2/2021
21:27
That was few months ago. Placing has been in discussion at 50p.
oilisgold
10/2/2021
21:26
We have experienced delays commercialising the Genedrive® 96 SARS CoV-2 test and the lack of revenue has impacted our cash position. However we continue to focus on obtaining product approvals and securing sales and we are managing the cost base until revenues are assured. We are confident in our sales forecasts but securing cash generative revenue in the forthcoming months is necessary otherwise the Group will haveto reduce costs and raise additional funds. We continue to adopt a going concern basis for the preparation of the accounts, but the combination of the above factors represents a material uncertainty that may cast significant doubt on the Group and Company's ability to continue as a going
oilisgold
10/2/2021
21:17
You cant rns lies son.I suggest you are bitter through loosing money somewhere....just get over it and move on.
countdracula55
10/2/2021
21:15
Lol. Amigo
professor_advfn
10/2/2021
21:15
Beckman RNS was just to pump this share up again
oilisgold
10/2/2021
21:14
Amaretto, well done for not buying. This will end in tears for many. REMEMBER THE LAST PUMP TO 300P AND THE DUMP TO 40P.
oilisgold
10/2/2021
20:24
A big RNS expected next week on Beckman sales
swerves1
Chat Pages: Latest  267  266  265  264  263  262  261  260  259  258  257  256  Older